Swedish Orphan Biovitrum AB (0MTD) Income Statement
Swedish Orphan Biovitrum AB Income Statement
Last quarter (Q3 2026), Swedish Orphan Biovitrum AB's total revenue was $9.12B, an increase of 17.34% from the same quarter last year. In Q3, Swedish Orphan Biovitrum AB's net income was $2.35B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 28.24B | $ 26.03B | $ 22.12B | $ 18.79B | $ 15.53B | |
| $ 12.32B | $ 20.24B | $ 9.95B | $ 13.98B | $ 12.04B | |
| $ 4.27B | $ 14.62B | $ 5.88B | $ 10.17B | $ 8.26B | |
| Depreciation and Amortization | $ 10.10B | $ 3.68B | $ 3.17B | $ 2.27B | $ 2.01B |
| $ 10.96B | $ 9.30B | $ 7.23B | $ 6.05B | $ 5.72B | |
| $ 8.05B | $ 5.63B | $ 4.07B | $ 3.81B | $ 3.73B | |
| $ -8.01B | $ -1.22B | $ -1.11B | $ -492.00M | $ -438.00M | |
| $ 34.00M | $ 4.41B | $ 2.95B | $ 3.32B | $ 3.29B | |
| $ 478.00M | $ 3.88B | $ 2.41B | $ 2.64B | $ 2.68B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.39 | $ 11.37 | $ 7.47 | $ 8.52 | $ 8.67 |
| Diluted EPS | $ 1.37 | $ 11.24 | $ 7.39 | $ 8.44 | $ 8.62 |
| Weighted Average Shares Outstanding | 344.30M | 341.73M | 322.66M | 309.48M | 308.90M |
| Weighted Average Shares Outstanding (Diluted) | 347.61M | 345.56M | 325.97M | 312.46M | 310.73M |
Currency in SEK